263 related articles for article (PubMed ID: 30745801)
1. MicroRNA-29a is a key regulon that regulates BRD4 and mitigates liver fibrosis in mice by inhibiting hepatic stellate cell activation.
Huang YH; Kuo HC; Yang YL; Wang FS
Int J Med Sci; 2019; 16(2):212-220. PubMed ID: 30745801
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-29a Alleviates Bile Duct Ligation Exacerbation of Hepatic Fibrosis in Mice through Epigenetic Control of Methyltransferases.
Yang YL; Wang FS; Li SC; Tiao MM; Huang YH
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106784
[TBL] [Abstract][Full Text] [Related]
3. Activation of Mir-29a in Activated Hepatic Stellate Cells Modulates Its Profibrogenic Phenotype through Inhibition of Histone Deacetylases 4.
Huang YH; Tiao MM; Huang LT; Chuang JH; Kuo KC; Yang YL; Wang FS
PLoS One; 2015; 10(8):e0136453. PubMed ID: 26305546
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-29a mitigation of toll-like receptor 2 and 4 signaling and alleviation of obstructive jaundice-induced fibrosis in mice.
Lin YC; Wang FS; Yang YL; Chuang YT; Huang YH
Biochem Biophys Res Commun; 2018 Feb; 496(3):880-886. PubMed ID: 29366780
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-29a mitigation of endoplasmic reticulum and autophagy aberrance counteracts in obstructive jaundice-induced fibrosis in mice.
Huang YH; Yang YL; Huang FC; Tiao MM; Lin YC; Tsai MH; Wang FS
Exp Biol Med (Maywood); 2018 Jan; 243(1):13-21. PubMed ID: 29105510
[TBL] [Abstract][Full Text] [Related]
6. Microarray Study of Pathway Analysis Expression Profile Associated with MicroRNA-29a with Regard to Murine Cholestatic Liver Injuries.
Li SC; Wang FS; Yang YL; Tiao MM; Chuang JH; Huang YH
Int J Mol Sci; 2016 Mar; 17(3):324. PubMed ID: 26938532
[TBL] [Abstract][Full Text] [Related]
7. Exogenous Therapeutics of Microrna-29a Attenuates Development of Hepatic Fibrosis in Cholestatic Animal Model through Regulation of Phosphoinositide 3-Kinase p85 Alpha.
Yang YL; Wang FS; Lin HY; Huang YH
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32455716
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-29a protects against acute liver injury in a mouse model of obstructive jaundice via inhibition of the extrinsic apoptosis pathway.
Tiao MM; Wang FS; Huang LT; Chuang JH; Kuo HC; Yang YL; Huang YH
Apoptosis; 2014 Jan; 19(1):30-41. PubMed ID: 24052410
[TBL] [Abstract][Full Text] [Related]
9. CXCL6-EGFR-induced Kupffer cells secrete TGF-β1 promoting hepatic stellate cell activation via the SMAD2/BRD4/C-MYC/EZH2 pathway in liver fibrosis.
Cai X; Li Z; Zhang Q; Qu Y; Xu M; Wan X; Lu L
J Cell Mol Med; 2018 Oct; 22(10):5050-5061. PubMed ID: 30106235
[TBL] [Abstract][Full Text] [Related]
10. EZH2-mediated inhibition of KLF14 expression promotes HSCs activation and liver fibrosis by downregulating PPARγ.
Du Z; Liu M; Wang Z; Lin Z; Feng Y; Tian D; Xia L
Cell Prolif; 2021 Jul; 54(7):e13072. PubMed ID: 34031939
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-29a Disrupts DNMT3b to Ameliorate Diet-Induced Non-Alcoholic Steatohepatitis in Mice.
Yang YL; Kuo HC; Wang FS; Huang YH
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30917489
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-29a-3p prevents Schistosoma japonicum-induced liver fibrosis by targeting Roundabout homolog 1 in hepatic stellate cells.
Kong H; Song Q; Hu W; Guo S; Xiang D; Huang S; Xu X; He J; Pan L; Tao R; Yu H; Huang J
Parasit Vectors; 2023 Jun; 16(1):184. PubMed ID: 37280619
[TBL] [Abstract][Full Text] [Related]
13. MiR-22-3p and miR-29a-3p synergistically inhibit hepatic stellate cell activation by targeting AKT3.
Wang Y; Zhang R; Li J; Han X; Lu H; Su J; Liu Y; Tian X; Wang M; Xiong Y; Lan T; Zhang G; Liu Z
Exp Biol Med (Maywood); 2022 Oct; 247(19):1712-1731. PubMed ID: 35833537
[TBL] [Abstract][Full Text] [Related]
14. Wnt Pathway Stabilizes MeCP2 Protein to Repress PPAR-γ in Activation of Hepatic Stellate Cells.
Kweon SM; Chi F; Higashiyama R; Lai K; Tsukamoto H
PLoS One; 2016; 11(5):e0156111. PubMed ID: 27214381
[TBL] [Abstract][Full Text] [Related]
15. Knockout of microRNA-21 reduces biliary hyperplasia and liver fibrosis in cholestatic bile duct ligated mice.
Kennedy LL; Meng F; Venter JK; Zhou T; Karstens WA; Hargrove LA; Wu N; Kyritsi K; Greene J; Invernizzi P; Bernuzzi F; Glaser SS; Francis HL; Alpini G
Lab Invest; 2016 Dec; 96(12):1256-1267. PubMed ID: 27775690
[TBL] [Abstract][Full Text] [Related]
16. Enhancer of Zeste Homologue 2 Inhibition Attenuates TGF-β Dependent Hepatic Stellate Cell Activation and Liver Fibrosis.
Martin-Mateos R; De Assuncao TM; Arab JP; Jalan-Sakrikar N; Yaqoob U; Greuter T; Verma VK; Mathison AJ; Cao S; Lomberk G; Mathurin P; Urrutia R; Huebert RC; Shah VH
Cell Mol Gastroenterol Hepatol; 2019; 7(1):197-209. PubMed ID: 30539787
[TBL] [Abstract][Full Text] [Related]
17. Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis.
Jiang Y; Xiang C; Zhong F; Zhang Y; Wang L; Zhao Y; Wang J; Ding C; Jin L; He F; Wang H
Theranostics; 2021; 11(1):361-378. PubMed ID: 33391480
[No Abstract] [Full Text] [Related]
18. JCAD deficiency attenuates activation of hepatic stellate cells and cholestatic fibrosis.
Xie L; Chen H; Zhang L; Ma Y; Zhou Y; Yang YY; Liu C; Wang YL; Yan YJ; Ding J; Teng X; Yang Q; Liu XP; Wu J
Clin Mol Hepatol; 2024 Apr; 30(2):206-224. PubMed ID: 38190829
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-29a Suppresses CD36 to Ameliorate High Fat Diet-Induced Steatohepatitis and Liver Fibrosis in Mice.
Lin HY; Wang FS; Yang YL; Huang YH
Cells; 2019 Oct; 8(10):. PubMed ID: 31652636
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-130a and -130b enhance activation of hepatic stellate cells by suppressing PPARγ expression: A rat fibrosis model study.
Lu L; Wang J; Lu H; Zhang G; Liu Y; Wang J; Zhang Y; Shang H; Ji H; Chen X; Duan Y; Li Y
Biochem Biophys Res Commun; 2015 Sep; 465(3):387-93. PubMed ID: 26255201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]